| Q36011190 | A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. |
| Q48318477 | Activation of JAK/STAT signal pathway predicts poor prognosis of patients with gliomas |
| Q34974091 | Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? |
| Q38125624 | Adiponectin: mechanisms and new therapeutic approaches for restoring diabetic heart sensitivity to ischemic post-conditioning |
| Q46151813 | CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion |
| Q33995071 | Cardiac preconditioning with sphingosine-1-phosphate requires activation of signal transducer and activator of transcription-3. |
| Q36899680 | Cardioplegia and diazoxide modulate STAT3 activation and DNA binding |
| Q90281531 | Ciliary neurotrophic factor signaling in the rat orbitofrontal cortex ameliorates stress-induced deficits in reversal learning |
| Q27008917 | Circadian influences on myocardial infarction |
| Q33982322 | Combination treatment for myeloproliferative neoplasms using JAK and pan-class I PI3K inhibitors |
| Q54580773 | Correlation analysis of JAK-STAT pathway components on prognosis of patients with prostate cancer. |
| Q34583556 | Critical role of the STAT3 pathway in the cardioprotective efficacy of zoniporide in a model of myocardial preservation – the rat isolated working heart |
| Q37008467 | Darbepoetin alfa exerts a cardioprotective effect in autoimmune cardiomyopathy via reduction of ER stress and activation of the PI3K/Akt and STAT3 pathways |
| Q39151222 | Delta Opioid Receptors and Cardioprotection. |
| Q37913053 | Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury |
| Q36895459 | Differential STAT3 signaling in the heart: Impact of concurrent signals and oxidative stress |
| Q28771386 | Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning |
| Q90424209 | EP4 activation ameliorates liver ischemia/reperfusion injury via ERK1/2‑GSK3β‑dependent MPTP inhibition |
| Q28752585 | Endogenous opiates and behavior: 2006 |
| Q42861824 | Ethanolamine is a novel STAT-3 dependent cardioprotective agent |
| Q36091471 | Glycogen synthase kinase 3 inhibitor protects against microvascular hyperpermeability following hemorrhagic shock |
| Q36895483 | High density lipoprotein/sphingosine-1-phosphate-induced cardioprotection: Role of STAT3 as part of the SAFE pathway |
| Q42126362 | Hydrogen sulfide postconditioning protects isolated rat hearts against ischemia and reperfusion injury mediated by the JAK2/STAT3 survival pathway |
| Q90469827 | Hyperglycemia-Induced Oxidative Stress Abrogates Remifentanil Preconditioning-Mediated Cardioprotection in Diabetic Rats by Impairing Caveolin-3-Modulated PI3K/Akt and JAK2/STAT3 Signaling |
| Q49629102 | Hypertrophied myocardium is vulnerable to ischemia/reperfusion injury and refractory to rapamycin-induced protection due to increased oxidative/nitrative stress |
| Q34755351 | IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. |
| Q60046136 | Identification of Crucial Genes and Pathways in Human Arrhythmogenic Right Ventricular Cardiomyopathy by Coexpression Analysis |
| Q37193667 | Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling |
| Q36907206 | Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice |
| Q36942410 | Inhibition of glycogen synthase kinase or the apoptotic protein p53 lowers the threshold of helium cardioprotection in vivo: the role of mitochondrial permeability transition |
| Q45012762 | Inhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling |
| Q28393594 | Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling |
| Q42548054 | Interleukin-27 Protects Cardiomyocyte-Like H9c2 Cells against Metabolic Syndrome: Role of STAT3 Signaling |
| Q36658981 | Intestinal epithelial cell-derived μ-opioid signaling protects against ischemia reperfusion injury through PI3K signaling |
| Q37430884 | JAK redux: a second look at the regulation and role of JAKs in the heart |
| Q83388306 | JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinoma |
| Q33595477 | Label-free cell phenotypic profiling decodes the composition and signaling of an endogenous ATP-sensitive potassium channel |
| Q38730374 | Long non-coding RNA MALAT1 functions as a mediator in cardioprotective effects of fentanyl in myocardial ischemia-reperfusion injury |
| Q42425263 | Mechanism of cardioprotective effect of erythropoietin-induced preconditioning in rat heart |
| Q36043450 | Morphine Reduces Myocardial Infarct Size via Heat Shock Protein 90 in Rodents |
| Q35587642 | Morphine and remifentanil-induced cardioprotection: its experimental and clinical outcomes |
| Q44338350 | Morphine induces mesangial cell proliferation and glomerulopathy via kappa-opioid receptors |
| Q33970045 | Morphine induces preconditioning via activation of mitochondrial K(Ca) channels |
| Q64078770 | Morphine promotes neovascularizing retinopathy in sickle transgeneic mice |
| Q35462875 | Morphine reduces the threshold of helium preconditioning against myocardial infarction: the role of opioid receptors in rabbits |
| Q35954209 | Morphine-Induced Preconditioning: Involvement of Protein Kinase A and Mitochondrial Permeability Transition Pore |
| Q35168195 | Mu opioid signaling protects against acute murine intestinal injury in a manner involving Stat3 signaling |
| Q51752588 | Multiple protective pathways against reperfusion injury: a SAFE path without Aktion? |
| Q36908289 | Myocardial AKT: the omnipresent nexus |
| Q36509072 | Myocardial Hypertrophic Remodeling and Impaired Left Ventricular Function in Mice with a Cardiac-Specific Deletion of Janus Kinase 2. |
| Q34659969 | Myocardial post-conditioning with Danshen-Gegen decoction protects against isoproterenol-induced myocardial injury via a PKCε/mKATP-mediated pathway in rats |
| Q58730374 | Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection |
| Q35286353 | Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart |
| Q27006830 | Opioid-induced cardioprotection |
| Q36852642 | PINK1 deficiency attenuates astrocyte proliferation through mitochondrial dysfunction, reduced AKT and increased p38 MAPK activation, and downregulation of EGFR. |
| Q84586659 | Pharmacological inhibition of GSK-3β produces late phase of cardioprotection in hyperlipidemic rat: possible involvement of HSP 72 |
| Q35426709 | Postconditioning inhibits myocardial apoptosis during prolonged reperfusion via a JAK2-STAT3-Bcl-2 pathway |
| Q28066192 | Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists |
| Q36392865 | Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. |
| Q36995201 | Regulating RISK: a role for JAK-STAT signaling in postconditioning? |
| Q42704632 | Regulation of signal transducer and activator of transcription 3 and apoptotic pathways by betaine attenuates isoproterenol-induced acute myocardial injury in rats |
| Q36217903 | Remote ischemic preconditioning for kidney protection: GSK3β-centric insights into the mechanism of action |
| Q37303154 | Role of glycogen synthase kinase-3beta in cardioprotection |
| Q36895468 | STAT transcription in the ischemic heart |
| Q54390219 | STAT3α interacts with nuclear GSK3beta and cytoplasmic RISK pathway and stabilizes rhythm in the anoxic-reoxygenated embryonic heart. |
| Q37739852 | Sevoflurane postconditioning protects the myocardium against ischemia/reperfusion injury via activation of the JAK2-STAT3 pathway |
| Q37000868 | Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt |
| Q42797586 | Signal transducer and activator of transcription 3 (STAT3) regulates adipocyte differentiation via peroxisome-proliferator-activated receptor gamma (PPARgamma). |
| Q36099739 | Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion |
| Q53639981 | Targeted deletion of regulatory T cells attenuates the protective effects of myocardial ischemic preconditioning in rats. |
| Q44335212 | The delta-opioid receptor agonist DADLE at reperfusion protects the heart through activation of pro-survival kinases via EGF receptor transactivation. |
| Q35810679 | The diabetic heart: too sweet for its own good? |
| Q34926847 | The δ-opioid receptor affects epidermal homeostasis via ERK-dependent inhibition of transcription factor POU2F3. |
| Q40597108 | Topical fentanyl stimulates healing of ischemic wounds in diabetic rats |
| Q39494703 | Urban particulate matter activates Akt in human lung cells |
| Q37838085 | When are pro-inflammatory cytokines SAFE in heart failure? |
| Q44335310 | δ-Opioid receptor (DOR) signaling and reactive oxygen species (ROS) mediate intermittent hypoxia induced protection of canine myocardium |